Uniplan Investment Counsel, Inc. Chroma Dex Corp. Transaction History

Uniplan Investment Counsel, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.74 - $6.7 $2.55 Million - $4.56 Million	-681,002 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.41 $10,508 - $18,082	1,737 Added 0.26%	681,002 $4.27 Million
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $57,236 - $93,846	8,594 Added 1.28%	679,265 $6.7 Million
Q1 2021 May 14, 2021	SELL	$4.59 - $18.74 $1.89 Million - $7.73 Million	-412,453 Reduced 38.08%	670,671 $6.26 Million
Q4 2020 Feb 12, 2021	BUY	$3.93 - $5.5 $706,224 - $988,355	179,701 Added 19.89%	1,083,124 $5.2 Million
Q3 2020 Nov 13, 2020	BUY	$4.01 - $5.56 $548,395 - $760,368	136,757 Added 17.84%	903,423 $3.62 Million
Q2 2020 Aug 14, 2020	SELL	$3.0 - $5.52 $52,776 - $97,107	-17,592 Reduced 2.24%	766,666 $3.52 Million
Q1 2020 May 15, 2020	BUY	$2.54 - $4.75 $277,251 - $518,481	109,154 Added 16.17%	784,258 $2.56 Million
Q4 2019 Feb 14, 2020	BUY	$2.83 - $4.61 $15,434 - $25,142	5,454 Added 0.81%	675,104 $2.91 Million
Q3 2019 Nov 14, 2019	SELL	$3.83 - $4.72 $136,271 - $167,937	-35,580 Reduced 5.05%	669,650 $2.64 Million
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $2.62 Million - $3.41 Million	705,230 New	705,230 $3.28 Million

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $509M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.